Sudden unexplained death in the young: epidemiology, aetiology and value of the clinically guided genetic screening

Aims To determine the incidence and the causes of sudden death (SD) in persons aged 1-35 years old and the diagnostic yield of clinically guided genetic screening in the sudden arrhythmic death syndrome (SADS) victims' families. Methods and results Incidence and causes of SD in the Attica region of Greece in 2002-10 were determined using death certificates and autopsy reports. We evaluated clinically consecutive families of SADS victims and if a clinical diagnosis was established, we proceeded to targeted genetic analysis. Out of 6030 deaths, 56% were due to traumatic or violent causes, 40.5% were natural deaths, and 3.3% were of undetermined cause. There were 349 SD cases. Cardiovascular causes accounted for 65%, non-cardiovascular causes for 17%, and SADS for 18%. Clinical evaluation identified an inherited heart disease in 5/20 SADS families (25%). Targeted genetic analysis identified a causative mutation in all of the five screened families and reconfirmed the diagnosis in three of five proband victims. Clinical and genetic evaluation of 28 family members identified eight affected carriers and eight non-affected carriers. Molecular autopsy failed to identify any of these families. Conclusion Sudden death in the young is of cardiovascular origin in the majority of cases. A considerable rate of SD cases remains of unknown cause on post-mortem. Apart from channelopathies, subclinical forms of inherited structural heart diseases would appear to be implicated in SADS. Clinically guided genetic screening has a significant diagnostic yield and identifies affected families that would have been missed by the current suggested molecular autopsy panel.

[1]  J. Skinner,et al.  A Prospective Study of Sudden Cardiac Death among Children and Young Adults. , 2016, The New England journal of medicine.

[2]  P. Lambiase,et al.  Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  A. Wilde,et al.  Improving usual care after sudden death in the young with focus on inherited cardiac diseases (the CAREFUL study): a community-based intervention study. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  E. Behr,et al.  The role of genetic testing in unexplained sudden death. , 2016, Translational research : the journal of laboratory and clinical medicine.

[5]  A. Wilde,et al.  Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives. , 2015, European heart journal.

[6]  E. Behr,et al.  The importance of specialist cardiac histopathological examination in the investigation of young sudden cardiac deaths. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  Wataru Shimizu,et al.  HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes , 2013 .

[8]  E. Behr,et al.  Sudden Cardiac Death With Autopsy Findings of Uncertain Significance: Potential for Erroneous Interpretation , 2013, Circulation. Arrhythmia and electrophysiology.

[9]  D. Tester,et al.  Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. , 2012, Mayo Clinic proceedings.

[10]  J. B. Oliveira,et al.  PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA). , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[11]  M. Ackerman,et al.  The Achilles’ Heel of Cardiovascular Genetic Testing: Distinguishing Pathogenic Mutations From Background Genetic Noise , 2011, Clinical pharmacology and therapeutics.

[12]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  A. Moss,et al.  Genetics of Sudden Cardiac Death , 2011, Current cardiology reports.

[14]  A. Wilde,et al.  Cardiogenetic screening of first-degree relatives after sudden cardiac death in the young: a population-based approach. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  J. Svendsen,et al.  Nationwide study of sudden cardiac death in persons aged 1-35 years. , 2011, European heart journal.

[16]  童鸿.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia： Proposed Modification of the Task Force Criteria , 2011 .

[17]  A. Wilde,et al.  Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. , 2010, Heart rhythm.

[18]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[19]  A. Wilde,et al.  Sudden Death in the Young: What Do We Know About It and How to Prevent? , 2010, Circulation. Arrhythmia and electrophysiology.

[20]  F. T. ten Cate,et al.  Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers. , 2009, European heart journal.

[21]  A. García-Alberola,et al.  Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic. , 2009, American Journal of Cardiology.

[22]  S. Priori,et al.  Yield of Genetic Screening in Inherited Cardiac Channelopathies: How to Prioritize Access to Genetic Testing , 2009, Circulation. Arrhythmia and electrophysiology.

[23]  E. Behr,et al.  Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death , 2007, Heart.

[24]  E. Behr,et al.  Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome , 2003, The Lancet.

[25]  G Thiene,et al.  Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings , 2001, Cardiovascular research.